27% Increase in Revenue to $4.4 million Coupled with 41% Decrease in Operating Costs and Expenses in 2Q 2025 Poised…
Announced first patient dosed in the Phase 2b placebo-controlled portion of the EP-104GI RESOLVE trial with topline data expected in…
Posts Positive Organic Growth and Adjusted EBITDA1 of 23.5% of Revenue CINCINNATI, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Quipt Home…
~ Revenue up 12% Year-over-Year to $25.1 Million ~ ~ Quarter Concluded with Class A Shares Being Added to Russell…
Total Company Revenue increased 8.4% to a quarterly record of $498.2 million in the second quarter of 2025 from $459.7…
CHANDLER, Ariz.--(BUSINESS WIRE)--Everspin Technologies, Inc. (NASDAQ: MRAM), the world’s leading developer and manufacturer of magnetoresistive random access memory (MRAM) persistent…
August 01, 2025 16:55 ET | Source: Xenon Pharmaceuticals Inc. VANCOUVER, British Columbia and BOSTON, Aug. 01, 2025 (GLOBE NEWSWIRE)…
Q2 consolidated revenue increased to AED 18.0 billion, a 28.1% year-on-year growthQ2 consolidated net profit rises to AED 3.5 billion, backed by…
Combined ratio on an IFRS basis was 99.6% for Q1FY26Retail GWP grew 18% YoY, with fresh retail premiums growth 25%…
~Through the Laboratory-Grown Diamond Facts Report, NDC counters growing myths and greenwashing in the lab-grown diamond industry~ MUMBAI, India, July…